✦ LIBER ✦

Gadolinium-based contrast agents and nephrotoxicity

✍ Scribed by Professor Sameh K. Morcos

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 26 KB
Volume: 68
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.20929

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gadolinium-based contrast agents and nep

Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures

✍ Carlo Briguori; Antonio Colombo; Flavio Airoldi; Gloria Melzi; Iassen Michev; Ma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Gadolinium-based contrast agents and nep

Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures

✍ Carlo Briguori 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB

Biodistribution of gadolinium-based cont

Biodistribution of gadolinium-based contrast agents, including gadolinium deposition

✍ Silvio Aime; Peter Caravan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

## Abstract The biodistribution of approved gadolinium (Gd)‐based contrast agents (GBCAs) is reviewed. After intravenous injection GBCAs distribute in the blood and the extracellular space and transiently through the excretory organs. Preclinical animal studies and the available clinical literature

Safety risks with gadolinium-based contr

Safety risks with gadolinium-based contrast agents

✍ Louis Marzella; Melanie Blank; Kate Gelperin; Rosemary Johann-Liang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

Gadolinium-based contrast agents and NSF

Gadolinium-based contrast agents and NSF: Evidence from animal experience

✍ Martin A. Sieber; Thomas Steger-Hartmann; Philipp Lengsfeld; Hubertus Pietsch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 927 KB

## Abstract Nephrogenic systemic fibrosis (NSF) is a potentially severe systemic disease typically characterized by fibrosis of the skin and connective tissues. The etiology of NSF is still unknown but is likely to be multifactorial. Specific triggers under scientific evaluation have included surge

Response to: Safety risks with gadoliniu

Response to: Safety risks with gadolinium-based contrast agents

✍ Honglei Zhang; Jeffrey H. Maki; Martin R. Prince 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB

We are grateful to Drs. Marzella, Blank, Gelperin, and Johann-Liang of the U.S. Food and Drug Administration for providing a timely update/reminder on the evolving safety concerns related to gadolinium and especially to Gadodiamide's association with nephrogenic systemic fibrosis (NSF) as well as th